Podcasts about Harvard Medical School

Dr. Jonathan Haywood Jenkins, Psy.D., CMPC, has spent more than a decade supporting athlete mental health and performance at Massachusetts General Brigham Hospital. As a member of the Harvard Medical School teaching community, he serves as Team Clinical and Performance Psychologist for the New England Patriots, Behavioral Sport Psychologist for the Boston Red Sox, and Sport Psychology Consultant for the Para Rowing Foundation. He is also the co-author of Mentality Wins: The Athlete's Playbook for Thriving in Sport and Life, currently the #1 New Release in Sport Psychology, a holistic guide to improving performance while protecting mental health. In this episode, Dr. Jenkins shares the Peachtree Approach and the deeper principles that drive sustainable success. Drawing from his own early speech and language challenges, his experience as a collegiate athlete, and his work with elite performers, he explains how adversity can become an advantage, how relationships fuel resilience, and why appreciating the good days prepares us for the hard ones. This conversation goes beyond sport. It's about leadership, perspective, and building a mentality that lasts. @dr.jonathanjenkins, @Unlimitedresilence, @mentalitywinsbook

We are in the information age and I don't believe there are any new topics and there is little, actual new information. But we can discover new insights and new angles and information that is more relevant for the current culture. And sometimes I just interest myself in an individual and their role within a topic and I want to hear their take on it. So with that said, in this episode I'm with Dr. Majid Fotuhi. Harper Collins, one of the world's big five publishers sent me a galley copy, which is a pre-copy before the book is actually published, of Majid's new book, “The Invincible Brain: The Clinically Proven Plan To Age-Proof Your Brain And Stay Sharp For Life.” I am very interested in brain health. I want to be cognitively sharp and able until my last breath. And I was interested in Majid's background. He  earned his PhD in Neuroscience from Johns Hopkins University and then his Medical Degree from Harvard Medical School, two institutions I greatly respect. Majid is currently an adjunct professor at the Mind/Brain Institute at Johns Hopkins University, while also teaching at George Washington University and Harvard Medical School. With 37 years of experience in teaching, clinical practice, and neuroscience research, Majid is a pioneer in enhancing brain vitality and cognitive performance and he developed a “Brain Fitness Program” that targets lifestyle optimization and cognitive stimulation to improve memory, focus, and overall brain health. The program has delivered measurable success for patients dealing with memory loss due to aging, concussions, and ADHD.  Sign up for your $1/month trial period at shopify.com/kevin Go to shipstation.com and use code KEVIN to start your free trial Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode Summary: In this enlightening conversation, Dr. Majid Fotuhi discusses the multifaceted nature of brain health, emphasizing the importance of understanding different types of intelligence, the power of practice and learning, and the interconnectedness of brain and body health. He addresses common misconceptions about memory and cognitive function, the impact of negative memories, and the role of genetics versus lifestyle in Alzheimer's disease. Dr. Fotuhi provides practical tips for enhancing brain function and encourages a holistic approach to maintaining cognitive health throughout life.Chapters00:00 Exploring Brain Intelligence03:02 The Power of Practice and Learning06:01 Understanding Memory and Cognitive Function08:39 The Interconnectedness of Brain and Body12:02 Overcoming Negative Memories and Trauma14:47 Alzheimer's Disease: Genetics vs. Lifestyle17:59 Holistic Approaches to Brain Health20:54 The Role of Stress and Emotional Well-being23:51 Practical Tips for Enhancing Brain Function26:55 Final Thoughts on Brain Health and LongevitySponsors: FATTY15 OFFER: Fatty15 is on a mission to replenish your C15 levels and restore your long-term health. You can get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/KIMBERLY and using code KIMBERLY at checkout.USE LINK: fatty15.com/KIMBERLY LMNTOFFER: Right now, for my listeners LMNT is offering a free sample pack with any LMNT drink mix purchase at DrinkLMNT.com/FEELGOOD. That's 8 single serving packets FREE with any LMNT any LMNT drink mix purchase. This deal is only available through my link so. Also try the new LMNT Sparkling — a bold, 16-ounce can of sparkling electrolyte water.USE LINK: DrinkLMNT.com/FEELGOOD Dr. Majid Fotuhi Resources: Book: The Invincible Brain: The Clinically Proven Plan to Age-Proof Your Brain and Stay Sharp for Life Website: neurogrow.com Social: YouTube @Dr. Majid Fotuhi Bio: Dr. Fotuhi earned his PhD in Neuroscience from Johns Hopkins University in 1992 and his Medical Degree from Harvard Medical School in 1997. Currently, he serves as an adjunct professor at the Mind/Brain Institute at Johns Hopkins University, while also teaching at George Washington University and Harvard Medical School.With 37 years of experience in teaching, clinical practice, and neuroscience research, Dr. Fotuhi has pioneered a multidisciplinary approach to enhancing brain vitality and cognitive performance at any age. His groundbreaking “Brain Fitness Program” combines a comprehensive baseline “Brain Portfolio” assessment with 12 bi-weekly brain training sessions. This program targets lifestyle optimization and cognitive stimulation to improve memory, focus, and overall brain health. Dr. Fotuhi's program has delivered measurable success for patients dealing with memory loss due to aging, concussions, and ADHD, as documented in several peer-reviewed journals. He is also the author of three books, including the highly acclaimed Boost Your Brain: The New Art and Science Behind Enhanced Brain Performance. Recognized as one of the leading experts in memory and successful aging, Dr. Fotuhi has delivered lectures at academic institutions and major organizations in over 20 countries – including a TEDx presentation in the Philippines. Passionate about sharing the latest discoveries in the field of brain rehabilitation and neuroplasticity, he has been featured in interviews with more than 50 prominent media outlets in the United States and around the globe.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Everyone is at risk of breast cancer. Some are more at risk than others due to hereditary factors – such as a family history of cancers – and lifestyle choices that affect our overall health. Knowing your risk of breast cancer can help you decide what steps to take to lower your risk. Joining me today is Dr. Jennifer Ligibel, a Susan G. Komen Scholar and Komen grantee, Professor of Medicine at Harvard Medical School, Senior Physician at the Dana-Farber Cancer Institute and an expert on the impact of lifestyle factors, cancer risk and outcomes. Through more than a dozen lifestyle intervention trials, Dr. Ligibel has evaluated the impact of exercise, weight loss, fitness, body composition and quality of life in cancer patients and survivors.

What is the real killer when it comes to heart disease? Can the right cardiac testing truly mean the difference between life and death? In today's episode, we are joined by Dr. John Osborne, a Harvard-trained, triple board-certified cardiologist and Co-Founder of ClearCardio, to break it all down… Dr. Osborne earned his B.S. with honors from Penn State University, his M.D. magna cum laude from Jefferson Medical College, and a Ph.D. in cardiovascular physiology from Thomas Jefferson University. His postdoctoral training at Harvard Medical School and Brigham and Women's Hospital helped shape his expertise in non-invasive cardiology. Board-certified across multiple disciplines, his work focuses on preventive cardiology, metabolic syndrome, and cardiovascular genetics. Recognized as the American Heart Association's Cardiac Care Provider of the Year and named a Top Doctor multiple times, Dr. Osborne has authored original research papers, book chapters, and delivered hundreds of international presentations. Through ClearCardio, he is advancing proactive cardiac care by integrating AI-powered imaging to detect plaque earlier, quantify risk more precisely, and empower patients before symptoms appear. In this episode, we dive into: What actually causes heart attacks and sudden cardiac death. The role of soft plaque vs calcified plaque in coronary artery disease. Why many heart attacks happen after a "normal" stress test. The limits of stents and why they do not necessarily extend longevity. To learn more about Dr. Osborne and his work with ClearCardio, connect with him on LinkedIn!

There is a palpable mix of excitement and anxiety about the latest impending wave of Artificial Intelligence. AI tools are being developed that will fundamentally impact our jobs, our relationships, our access to knowledge and creativity, our children's lives, and our planet. But for an industry like healthcare — where fax machines and pagers are common, where people struggle to find affordable care or adequate resources, and nurses are leaving the profession due to administrative burdens and moral distress — can AI be an answer?  In this two-part feature of our AI in Play series, where we explore AI's role in transforming healthcare, host Oriana Beaudet, Vice President of Innovation at the American Nurses Association, Credentialing Center, and Foundation, talks with a nurse and a clinician helping to shape the future of AI in healthcare for one of the largest technology companies in the world.   Episode 130 features nurse Mary Varghese-Presti, Corporate VP and COO of Microsoft Health and Life Sciences, whose team built Dragon Copilot, the first commercially available ambient AI solution purpose-built for nursing workflows. We learn how Microsoft co-designed this tool directly with staff nurses, nurse managers, and nurse executives across more than 10 health systems,  and why that collaboration is essential. We'll learn about Microsoft's vision for a three-stage AI future, from co-pilots to agents to a true hybrid workforce, and what it would mean for nurses to have the ability to delegate tasks the way physicians have long been able to do. Finally, we hear the deeply personal story behind Mary's mission,  from growing up in an immigrant household surrounded by nurse "aunties," to advocating for a voiceless patient at 4 am as a young nurse at Johns Hopkins, to now leading the technology that she believes will restore humanity and dignity to the very profession that shaped her.  Episode 131 features Dominic King, former surgeon and VP of Health at Microsoft AI, where his team builds and scales consumer health tools that see more than 50 million health-related sessions a day. In this conversation, we learn about Microsoft's partnership with Harvard Medical School and how it's working to ensure that the billions of health questions people ask AI every day are met with credible, clinically sound information. We also hear how he thinks about patient safety and trust in AI, and we'll get his candid take on what AI cannot replace, why clinicians must be central to scaling these tools beyond the pilot stage, and how he believes technology is the single biggest lever for making health systems sustainable in the face of growing global demand.    For more information on the podcast bundles, visit ANA's Innovation Website at https://www.nursingworld.org/practice-policy/innovation/education.    Have questions or feedback for the SEE YOU NOW team?  Future episode ideas? Contact us at hello@seeyounowpodcast.com. 

There is a palpable mix of excitement and anxiety about the latest impending wave of Artificial Intelligence. AI tools are being developed that will fundamentally impact our jobs, our relationships, our access to knowledge and creativity, our children's lives, and our planet. But for an industry like healthcare — where fax machines and pagers are common, where people struggle to find affordable care or adequate resources, and nurses are leaving the profession due to administrative burdens and moral distress — can AI be an answer?  In this two-part feature of our AI in Play series, where we explore AI's role in transforming healthcare, host Oriana Beaudet, Vice President of Innovation at the American Nurses Association, Credentialing Center, and Foundation, talks with a nurse and a clinician helping to shape the future of AI in healthcare for one of the largest technology companies in the world.   Episode 130 features nurse Mary Varghese-Presti, Corporate VP and COO of Microsoft Health and Life Sciences, whose team built Dragon Copilot, the first commercially available ambient AI solution purpose-built for nursing workflows. We learn how Microsoft co-designed this tool directly with staff nurses, nurse managers, and nurse executives across more than 10 health systems,  and why that collaboration is essential. We'll learn about Microsoft's vision for a three-stage AI future, from co-pilots to agents to a true hybrid workforce, and what it would mean for nurses to have the ability to delegate tasks the way physicians have long been able to do. Finally, we hear the deeply personal story behind Mary's mission,  from growing up in an immigrant household surrounded by nurse "aunties," to advocating for a voiceless patient at 4 am as a young nurse at Johns Hopkins, to now leading the technology that she believes will restore humanity and dignity to the very profession that shaped her.  Episode 131 features Dominic King, former surgeon and VP of Health at Microsoft AI, where his team builds and scales consumer health tools that see more than 50 million health-related sessions a day. In this conversation, we learn about Microsoft's partnership with Harvard Medical School and how it's working to ensure that the billions of health questions people ask AI every day are met with credible, clinically sound information. We also hear how he thinks about patient safety and trust in AI, and we'll get his candid take on what AI cannot replace, why clinicians must be central to scaling these tools beyond the pilot stage, and how he believes technology is the single biggest lever for making health systems sustainable in the face of growing global demand.      For more information on the podcast bundles, visit ANA's Innovation Website at https://www.nursingworld.org/practice-policy/innovation/education.    Have questions or feedback for the SEE YOU NOW team?  Future episode ideas? Contact us at hello@seeyounowpodcast.com.       

On this episode of the AMSSM Sports Medcast (X: @TheAMSSM), host Dr. Jeremy Schroeder, DO (X: @thejschro), is joined by Dr. Adam Tenforde, MD, to provide a preview of the Extracorporeal Shockwave Therapy (ESWT) Pre-Conference that will take place during the 2026 AMSSM Annual Meeting. Dr. Tenforde is a sports medicine physician and an assistant professor in the Department of Physical Medicine and Rehabilitation at Harvard Medical School. He is also the Director of Running Medicine at Spaulding National Running Center and the Co-Director of Harvard Sports Medicine. As a former elite distance runner, he has a great interest in running medicine, bone health, prevention, and management of overuse injuries. In-person and virtual attendance options are still available for the conference. Register to attend the 2026 AMSSM Annual Meeting at annualmeeting.amssm.org.

In today's episode, we sat down with Sarah Sammons, MD. Dr Sammons is associate director of the Metastatic Breast Cancer Program and a senior physician at Dana-Farber Cancer Institute, as well as an assistant professor of medicine at Harvard Medical School, both in Boston, Massachusetts.In our exclusive interview, Dr Sammons discussed the rationale for and findings from a phase 2 study (NCT06449222) evaluating the PD-L1– and VEGF-A–directed bispecific antibody pumitamig (BNT327/BMS986545) in patients with locally advanced or metastatic triple-negative breast cancer (TNBC), as well as what these data may mean for the TNBC treatment paradigm.

These days people are using AI chatbots for everything. These chatbots have a wealth of information at their metaphorical fingertips. But the accuracy of the information that they offer us is, well, questionable. But it makes sense why some people turn to AI for medical advice. They’re usually free, which gives them an upper hand when healthcare in the United States is so expensive. They’re also easy to access, so people can get their questions answered immediately, instead of waiting for an opening at their doctor’s office. And they’re trained to be empathic, which is especially appealing to patients who don’t feel valued in medical settings. In this "Ask a Doctor" segment, we explore the world of health advice and chatbots with two medical professionals. Guests: Angad Singh is a family medicine physician. He's also an Associate Chief Clinical Information Officer and Clinical Associate Professor at UW Medicine. Danielle Bitterman is an assistant Professor at Harvard Medical School and Clinical Lead for Data Science and AI at Mass General Brigham. Related links: A.I. Chatbots Are Changing How Patients Get Medical Advice - The New York Times How to Use ChatGPT for Health Advice | Right as Rain Health Advice From A.I. Chatbots Is Frequently Wrong, Study Shows - The New York Times Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.See omnystudio.com/listener for privacy information.

Last time we talked about kidney xenotransplantation, we were joined by Towana Loony and Tim Andrews, who shared their personal experiences with receiving a xenotransplant. Today, two doctors who helped propel xenotransplantation forward, Dr. Vineeta Kumar and Dr. Leonardo Riella, are here to explain the science and what comes next. This episode is supported by eGenesis and United Therapeutics In this episode we heard from:  Vineeta Kumar is the lead nephrologist for UAB's Living Kidney Donor and Incompatible Kidney Transplant programs. She is an expert in kidney transplantation, living kidney donation, incompatible kidney transplant, kidney paired donation and cardiovascular outcomes after kidney transplantation. Kumar also engages in research in the prevention, treatment and prognosis of antibody mediated rejection. She has been named a "Top Doctor" by U.S. News & World Report each year since 2012. She has been lead facilitator of the UAB Schwartz Rounds since 2009, a program that brings together nurses, physicians, social workers, and other providers to discuss delivery of compassionate care. She was awarded the Brewer-Heslin Endowed Award for Professionalism in Medicine for the highly skilled and compassionate medical care she provides to her patients. Kumar was recently named "Best Educator" by the 2018, 2019 and 2020 UAB Medical School classes. She has previously served on the Education Committee for the American Society of Transplantation. Leonardo V. Riella, M.D., Ph.D. is the Harold and Ellen Danser Endowed Chair in Transplant Surgery at Harvard Medical School and the Medical Director of Kidney Transplantation at Massachusetts General Hospital. His research focuses on mechanisms of immune regulation and the development of novel therapies to promote transplant tolerance. In addressing kidney disease recurrence post-transplantation, he founded and leads the TANGO Consortium, the largest global effort dedicated to studying glomerular disease recurrence. In March 2024, Dr. Riella led the world's first successful kidney xenotransplant from a gene-edited pig into a living human. He now leads the first FDA-approved pilot study in kidney xenotransplantation and is conducting high-dimensional immune profiling studies to characterize the human xeno-immune response and guide immunosuppressive strategies. Find out more about Dr. Riella's research here.     Additional Resources Xenotransplantation Information   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

Bruce Chabner is a professor of medicine at Harvard Medical School and clinical director emeritus of the Massachusetts General Hospital Cancer Center. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. I.D. Goldman and B.A. Chabner. Cerebral Folate Deficiency, Autism, and the Role of Leucovorin. N Engl J Med 2026;394:833-835.

This time on Code WACK! Why do Americans live about four years less, on average, than people in similar European countries, despite spending far more on health care? And why are so many dying from illnesses we already know how to prevent or treat? To help us unpack this, we spoke with Dr. Adam Gaffney — a pulmonary and critical care physician, public health researcher, and Assistant Professor of Medicine at Harvard Medical School. He's a former president of Physicians for a National Health Program, and his research and advocacy focus on health care financing and national reform. He's also the author of To Heal Humankind: The Right to Health in History. This is part one of a two-part series. Check out the Transcript and Show Notes for more! Keep Code WACK! on the air with a tax-deductible donation at heal-ca.org/donate.

From Discovery to Delivery: Charting Progress in Gynecologic Oncology, hosted by Ursula A. Matulonis, MD, brings expert insights into the most recent breakthroughs, evolving standards, and emerging therapies across gynecologic cancers. Dr Matulonis is chief of the Division of Gynecologic Oncology and the Brock-Wilcon Family Chair at the Dana-Farber Cancer Institute, as well as a professor of medicine at Harvard Medical School, both in Boston, Massachusetts.In this episode, Dr Matulonis sat down with guest Susana M. Campos, MD, MPH. Dr Campos is the clinical director and director of Educational Initiatives for the of the Division of Gynecologic Oncology at Dana-Farber Cancer Institute, and an institute physician and assistant professor of medicine at Harvard Medical School in Boston, Massachusetts. Drs Matulonis and Campos discussed the evolving landscape of newly diagnosed cervical cancer, from epidemiologic trends to emerging therapeutic strategies.According to 2026 estimates from the American Cancer Society, approximately 13,400 new cases of invasive cervical cancer will be diagnosed in the United States, with roughly 4200 deaths. Although incidence has declined over time due to human papillomavirus (HPV) vaccination and screening efforts, rates have plateaued, and the disease burden remains substantial, particularly among women aged 35 to 64 years. Dr Campos noted that approximately half of cases occur in women younger than 50 years of age, and about 20% are diagnosed in women older than 65 years of age.Dr Campos reviewed common presenting symptoms, including abnormal vaginal bleeding, intermenstrual or postmenopausal bleeding, abnormal discharge, pelvic pain, and, in advanced cases, urinary symptoms or leg swelling. She explained that diagnosis begins with pelvic examination and cervical cytology or HPV testing, followed by colposcopy and biopsy when indicated. Although cervical cancer remains one of the few malignancies that is clinically staged, imaging modalities, such as MRI, CT, and PET scans, are critical to accurately defining disease extent, they underscored. Moreover, the discussion highlighted transformative advances in locally advanced disease. The phase 3 KEYNOTE-A18 trial (NCT04221945) demonstrated improved progression-free and overall survival with the addition of pembrolizumab (Keytruda) to standard chemoradiation, establishing a new standard for high-risk patients, Campos stated. Similarly, the phase 3 INTERLACE trial (NCT01566240) showed that short-course induction chemotherapy with carboplatin and paclitaxel before chemoradiation improved long-term outcomes. Campos forecasted that ongoing studies, including the phase 3 NRG-GY037 trial (NCT07061977), may integrate these approaches and further refine optimal treatment sequencing.Lastly, Drs Matulonis and Campos highlighted the expanding therapeutic arsenal in the recurrent and metastatic setting. Campos noted how antibody-drug conjugates, such as tisotumab vedotin-tftv (Tivdak) and fam-trastuzumab deruxtecan-nxki (Enhertu), have demonstrated meaningful activity, particularly in biomarker-selected populations. Campos added that investigational strategies targeting TROP2, such as sacituzumab govitecan-hziy (Trodelvy), represent additional promising avenues.Despite these advances, both experts emphasized that prevention remains paramount. Widespread uptake of HPV vaccination, including the 9-valent vaccine, as well as adherence to routine cervical screening, are essential to reducing the long-term burden of this largely preventable disease.

Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Jodi Gilman, Department of Psychiatry at Harvard Medical School and Massachusetts General Hospital. Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Dr Jodi Gilman, Associate Professor of Psychology in the Department of Psychiatry at Harvard Medical School and Massachusetts General Hospital. In the February 2026 podcast Jodi Gilman talks about their secondary analysis of a randomised clinical trial looking at cannabis use and nicotine vaping cessation outcomes among adolescents and young adults. Participants were 16 to 25 and reported vaping nicotine regularly and did not smoke tobacco. The full study assessed the efficacy of varenicline for nicotine vaping cessation. For more detail on the parent trial listen to the interview with Eden Evins in the April 2025 podcast. Jodi Gilman discusses the finding that, among adolescents and young adults attempting to reduce or stop nicotine vaping, baseline cannabis use was not associated with nicotine vaping abstinence. Varenicline was helpful for nicotine vaping cessation regardless of cannabis use. This finding indicates that co-use of cannabis may not be a barrier to successful nicotine vaping cessation treatment. This podcast is a companion to the electronic cigarettes Cochrane living systematic review and Interventions for quitting vaping review and shares the evidence from the monthly searches. Reference for the paper by Gilman discussed in this podcast, January 2026 search: 10.1001/jamanetworkopen.2025.47799. Parent study by Evins: 10.1001/jama.2025.3810. Our searches for the EC for smoking cessation review carried out on 1st February 2026 found: 4 linked reports (10.1016/j.cct.2026.108215; 1; 0.1111/add.70294; 10.1007/s11606-024-08797-5; 10.1016/j.lana.2025.101351) Our search for our interventions for quitting vaping review carried out on 1st February 2026 found: 1 new study (10.1111/jrh.70109) and 2 linked reports (10.1002/adaw.34496; 10.1007/s11606-024-08797-5). For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review of E-cigarettes for smoking cessation updated in November 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub10/full For more information on the full Cochrane review of Interventions for quitting vaping published in November 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016058.pub3/full This podcast is supported by Cancer Research UK.

Dr. Ross Greene's work has profoundly shaped how so many of us think about kids' behavior and what they actually need from the adults in their lives, so I'm thrilled to welcome him back to the show to talk about his brand new book, The Kids Who Aren't Okay: The Urgent Case for Reimagining Support, Belonging, and Hope in Schools. Together, we explore the urgent need to reimagine how we support children in schools, especially as mental health concerns continue to rise. We dig into the importance of recognizing developmental variability, why meeting kids where they are is non-negotiable, and how current behavior-focused systems miss the real problems underneath. Ross also highlights the role parents and caregivers can play in advocating for meaningful change. About Dr. Ross Greene  Ross W. Greene, Ph.D., is a clinical psychologist and the originator of the innovative, evidence-based approach called Collaborative & Proactive Solutions (CPS), as described in his influential books The Explosive Child, Lost at School, Lost & Found, and Raising Human Beings. He also developed and executive produced the award-winning documentary film The Kids We Lose, released in 2018. Dr. Greene was on the faculty at Harvard Medical School for over 20 years, and is now founding director of the non-profit Lives in the Balance. He is also currently adjunct Professor in the Department of Psychology at Virginia Tech and adjunct Professor in the Faculty of Science at the University of Technology in Sydney, Australia. Dr. Greene has worked with several thousand kids with concerning behaviors and their caregivers, and he and his colleagues have overseen implementation and evaluation of the CPS model in countless schools, inpatient psychiatric units, and residential and juvenile detention facilities, with dramatic effect: significant reductions in recidivism, discipline referrals, detentions, suspensions, and use of restraint and seclusion. Dr.Greene lectures throughout the world and lives in Freeport, Maine. Things you'll learn from this episode  How kids today are facing unprecedented challenges that require new ways of thinking and responding Why developmental variability matters and why every child needs support tailored to their unique profile How schools can create more supportive ecosystems by using proactive rather than reactive approaches Why behavior is often a late signal of unmet expectations, not the problem itself How managing expectations and understanding root causes can reduce concerning behaviors Why parents' advocacy and the Collaborative & Proactive Solutions model can transform how children are supported in education Resources mentioned The Kids Who Aren't Okay: The Urgent Case for Reimagining Support, Belonging, and Hope in Schools by Dr. Ross Greene Never Too Early: CPS with Young Kids (documentary) The Explosive Child: A New Approach for Understanding and Parenting Easily Frustrated, Chronically Inflexible Children by Dr. Ross Greene Lives in the Balance (Dr. Greene's website) The B Team (Facebook group) Lost at School: Why Our Kids With Behavioral Challenges are Falling Through the Cracks and How We Can Help Them by Dr. Ross Greene Raising Human Beings: Creating a Collaborative Partnership with Your Child by Dr. Ross Greene Lost and Found: Helping Behaviorally Challenge Students (and While You're At It, All the Others by Dr. Ross Greene The Kids We Lose (documentary) How to Parent Angry and Explosive Children, with Dr. Ross Greene (Tilt Parenting podcast) Ken Wilbur Learn more about your ad choices. Visit podcastchoices.com/adchoices

Conversations about brain health have been dominated by a competing mix of fatalism and over-promising, with aging framed as inevitable decline and "brain optimisation" sold through weak evidence. So how should we think about cognition across the lifespan? In this episode, we explore the idea that neuroplasticity does not disappear in adulthood, but instead continues to respond, for better or worse, to repeated behaviours and exposures. Much of what is labelled age-related cognitive decline may in fact reflect an accumulation of modifiable risk factors. We also dig into how to critically evaluate brain-health claims and how lifestyle pillars such as exercise, sleep, diet, stress reduction and cognitive training fit into a coherent framework. The discussion extends to emerging multimodal intervention programs, their promising signals and their clear limitations, and to a broader, multifactorial view of Alzheimer's disease that moves beyond a narrow amyloid-centric model. Finally, we examine the role of genetics, including ApoE4, and why genetic risk does not equate to biological destiny, even later in life. Dr. Majid Fotuhi is a neurologist and an adjunct professor at the Johns Hopkins Mind/Brain Institute. He earned his medical degree from Harvard Medical School and completed a Ph.D. in neuroscience at Johns Hopkins University. That was followed by internship and neurology residency at Johns Hopkins Hospital. Timestamps [03:41] Understanding neuroplasticity [05:22] Risk factors for cognitive decline [07:07] Evidence-based interventions for brain health [09:37] The five pillars of brain health [10:42] Dr. Fotuhi's multimodal program [19:09] Measuring cognitive function [24:43] The role of amyloid and tau in Alzheimer's [27:53] Genetics and lifestyle in brain health [30:03] Debunking myths and overhyped claims [36:08] Key ideas segment (premium subscribers only) Related Resources Go to episode page (with links to studies mentioned) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Dr. Fotuhi's book: The Invincible Brain

Bone loss doesn't start when fractures happen — it begins years earlier. In this episode, we explore how bone aging accelerates during menopause and the emerging role of the gut microbiome as a driver of skeletal decline. Dr. Kara Fitzgerald speaks with research scientists from Sōlaria biō, the company behind Bōndia, about their work studying plant-derived microbes, microbial synergies, and the connections between gut health, inflammation, and bone loss in peri- and postmenopausal women. We also review findings from a randomized, placebo-controlled clinical trial examining a microbiome-based intervention for bone health — and discuss why bone loss may need to be addressed earlier, systemically, and beyond hormones alone. Full show notes + references: https://www.drkarafitzgerald.com/fxmed-podcast/ GUEST DETAILS Alicia Ballok, Ph.D. is Director of Discovery at Sōlaria biō, leading research on plant-derived synbiotics for inflammatory and immune-mediated diseases. Trained in Microbiology and Immunology at Dartmouth, with postdoctoral work at Harvard Medical School and Massachusetts General Hospital, her work focuses on translating host–microbe science into therapeutic innovation. Mark Charbonneau, Ph.D. is Vice President of R&D at Sōlaria biō. He earned his Ph.D. in Computational and Systems Biology at Washington University in St. Louis, studying infant microbiome development and undernutrition. His work spans microbiome research, bioinformatics, and live biotherapeutic innovation. THANKS TO OUR SPONSOR Sōlaria biō: http://bit.ly/SolariaBio EXCLUSIVE OFFER FOR NEW FRONTIERS LISTENERS Looking for a clinically proven way to target bone loss? Bōndia by Sōlaria biō is a groundbreaking blend of plant-derived prebiotics and probiotics shown in a clinical trial to improve bone density outcomes by 85%. Try it for yourself at Sōlaria biō and use code Kara20 for 20% off your order. CONNECT with DrKF Want more? Join our newsletter here: https://www.drkarafitzgerald.com/newsletter/ Or take our pop quiz and test your BioAge! https://www.drkarafitzgerald.com/bioagequiz YouTube: https://tinyurl.com/hjpc8daz Instagram: https://www.instagram.com/drkarafitzgerald/ Facebook: https://www.facebook.com/DrKaraFitzgerald/ DrKF Clinic: Patient consults with DrKF physicians including Younger You Concierge: https://tinyurl.com/yx4fjhkb Younger You Practitioner Training Program: www.drkarafitzgerald.com/trainingyyi/ Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw

This time on Code WACK! Why do Americans live about four years less, on average, than people in similar European countries, despite spending far more on health care? And why are so many dying from illnesses we already know how to prevent or treat? To help us unpack this, we spoke with Dr. Adam Gaffney - a pulmonary and critical care physician, public health researcher, and Assistant Professor of Medicine at Harvard Medical School. He's a former president of Physicians for a National Health Program, and his research and advocacy focus on health care financing and national reform. He's also the author of To Heal Humankind: The Right to Health in History. This is part one of a two-part series. Check out the Transcript and Show Notes for more!  Keep Code WACK! on the air with a tax-deductible donation at heal-ca.org/donate.   

This time on Code WACK! Why do Americans live about four years less, on average, than people in similar European countries, despite spending far more on health care? And why are so many dying from illnesses we already know how to prevent or treat? To help us unpack this, we spoke with Dr. Adam Gaffney — a pulmonary and critical care physician, public health researcher, and Assistant Professor of Medicine at Harvard Medical School. He's a former president of Physicians for a National Health Program, and his research and advocacy focus on health care financing and national reform. He's also the author of To Heal Humankind: The Right to Health in History. This is part one of a two-part series. Check out the Transcript and Show Notes for more! Keep Code WACK! on the air with a tax-deductible donation at heal-ca.org/donate.

From Music to Medicine: Rethinking Clinical Trials, AI, and Real-World Evidence On this episode Gil and Gregg welcome Amir Lahav, MD, ScD, founder and CEO of SkyMedAI and curator of the Digital Health AI Innovation Summit in Boston. Dr. Lahav traces his unlikely path from working musician to Harvard Medical School faculty, Pfizer rare-disease innovator, and now advisor to digital health and life sciences companies. The conversation explores how music-driven neurorehabilitation helped stroke survivors regain motor function, why traditional snapshot-based clinical trials are “embarrassingly wrong” for real-world patients, and how AI and wearables can turn continuous data into earlier detection and more humane care. Lahav also warns about overconfident, under-validated AI and argues that the most successful health companies by 2030 will be those that know when not to use AI. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode, we explore the treatment algorithm for adult ADHD with Dr. Oscar Bukstein from Harvard Medical School. Should you start with stimulants or non-stimulants when substance use disorder complicates the picture? Discover how comorbidities like depression and anxiety reshape your medication selection strategy for optimal patient outcomes. Faculty: Oscar G. Bukstein, M.D., M.P.H Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Mastering Adult ADHD: A Comprehensive Clinical Guide Treatment Algorithm for Adult ADHD

In this episode of Do Good to Lead Well, I welcome Dr. Jacqueline Sperling, a clinical psychologist, assistant professor in psychology at Harvard Medical School, and the co-founder and co-program director of the McLean Anxiety Mastery Program at McLean Hospital to discuss her latest book, “Find Your Fierce: How to Put Social Anxiety in Its Place.”Motivated by long waitlists at treatment centers and the slow path many face toward accessing help for social anxiety, Jacqueline Sperling shares her mission: to offer practical, evidence-based tools that anyone can use, regardless of clinical diagnosis or age. She grounds her message in empowerment, emphasizing that anxiety is a universal emotion—sometimes adaptive, sometimes disruptive—but always manageable with the right approach.Major themes include: • Understanding Anxiety: Dr. Sperling defines anxiety as a forward-looking form of fear and reframes it as a resource that can help us prepare for life's challenges, provided we don't let it dominate our decision-making. • The Thoughts-Feelings-Behaviors Model: Our discussion breaks down how our internal dialogue, emotions, and actions interconnect. Techniques like “stop, drop, and roll” and identification of unhelpful thought categories (catastrophizing, shoulds, overgeneralizing) are brought to life through questions from the live audience. • Leadership and Team Dynamics: We explore how leaders can compassionately address anxiety in their teams, foster psychological safety, and model healthy boundaries, which are especially during disruptive times and organizational uncertainty.Check out this episode for an honest, caring invitation for how we can create lasting mental health hygiene: a daily, mindful practice to care for ourselves, as we pursue meaningful work and lead with compassion.What You'll Learn- How to flip the script when you always expect the worst.- How leaders can compassionately support team members stuck in negative thought cycles.- Strategies for dealing with imposter syndrome and perfectionism.- Practical tips for receiving feedback without defensiveness.- Ways to maintain resilience in uncertain, disruptive times.- The power of mental health hygiene.Podcast Timestamps02:15 Dr. Jacqueline Sperling's background04:07 Origin story of "Find Your Fierce" book05:48 Understanding anxiety vs. fear07:49 The three-component model (thoughts, feelings, behaviors)10:04 Stop, drop, and roll technique14:23 Managing catastrophizing in team members18:54 Addressing imposter syndrome23:01 Overcoming fear of speaking up in meetings28:08 Values-based anxiety management31:53 The "shoulds" and "musts" trap33:51 Receiving feedback effectively38:03 Managing team anxiety during disruption40:06 Addressing perfectionism44:40 Delegation and leadership anxiety48:33 Overgeneralizing dangers52:07 Mental health hygiene practicesKEYWORDSPositive Leadership, Managing Anxiety, Social Anxiety, Thought-Feeling-Behavior Model, Catastrophizing, Mindfulness, Imposter Syndrome, Perfectionism, Exposure Therapy, Behavioral Experiments, Self-insight, Mental Health Hygiene, Resilience, Stress Management, Reframing, Team Dynamics, Sleep Hygiene, Self-care, CEO Success

Dr. Halley Alexander and Dr. Alissa M. D'Gama discuss genetic testing for infantile epilepsies.  Show citation:  Nguyen JNH, Lachgar-Ruiz M, Higginbotham EJ, et al. Diagnostic Yield of Comprehensive Reanalysis After Nondiagnostic Short-Read Genome Sequencing in Infants With Unexplained Epilepsy. Neurology. 2026;106(6):e214645. doi:10.1212/WNL.0000000000214645  Show transcript:  Dr. Halley Alexander:  Hi, this is Halley Alexander with today's Neurology Minute, and I'm here with Dr. Alissa D'Gama from Boston Children's Hospital and Harvard Medical School, and we just finished recording a full-length podcast about some exciting new work in genetic testing for infantile onset epilepsies. Alissa, can you tell us what you found briefly and why it's important for neurology care? Dr. Alissa D'Gama:  Infantile epilepsies are relatively common, and they're associated with substantial burden of disease, and we know that identifying underlying genetic causes can impact clinical care. It's important for emerging precision therapies. But even after genome sequencing, which is the most comprehensive clinical genetic testing currently available, most infants remain genetically unsolved. And so what we did was take that genome sequencing data and reanalyze it for a cohort of infants who had unexplained non-acquired epilepsy and non-diagnostic genome sequencing, and in about 5% of cases, our reanalysis was able to identify a genetic diagnosis, and all of these diagnoses had impact on clinical care for their infants and their families. In some cases, we could incorporate new information, either new clinical information about the patient or new scientific methods or information about disease associations, and in other cases, we were able to incorporate new analysis methods to identify variants. And so our findings suggest that implementing reanalysis for infants or any individual with epilepsy within a year or two of non-diagnostic testing may be useful. Dr. Halley Alexander:  Thank you so much, and you can find a lot more details by listening to the full-length podcast, which is available now on the Neurology podcast, and you can find the full article in the March 10th issue of Neurology or online at neurology.org. As always, thanks for tuning in for today's Neurology Minute. 

In this episode, host Sandy Vance chats with Dr. Sean Kelly, the Chief Medical Officer and the SVP of Customer Healthcare Strategy at Imprivata. Together, they unpack how healthcare organizations can strengthen cybersecurity without slowing clinicians down—exploring everything from mobile device security and passwordless authentication to adaptive authentication, risky user behaviors, and the very real implications for patient safety, workflow efficiency, and ROI for healthcare leaders.In this episode, they talk about:How cybersecurity can be improvedThe impact that Imprivata has on clinicians Why multi-factor authentication systems aren't more prevalent in the healthcare industryThe risky behaviors that open up organizations to security risksThe different things that Imprivata offers organizationsThe risks of patient harm in cybersecurity and privacyAdvice for CIOs or CFOs: workflow implications, security compliance, security and efficiency ROI, and financial valueAdaptive authentication at ImprivataA Little About Sean:Dr. Sean Kelly brings a uniquely well-rounded perspective to healthcare, shaped by a career that spans emergency medicine, healthcare leadership, technology, teaching, and entrepreneurship. An emergency physician at Beth Israel Lahey Health in Boston and an Assistant Clinical Professor of Emergency Medicine at Harvard Medical School, he is also the Chief Medical Officer and SVP of Customer Healthcare Strategy at Imprivata, where he helps guide product vision, go-to-market strategy, and customer experience after more than a decade with the company from startup through IPO and private equity ownership. He has led high-performing teams in both clinical and executive settings, contributed to care delivery improvements impacting millions of patients, published widely in emergency medicine and medical education, and earned multiple teaching awards. His background includes training at Harvard College, UMass Medical School, and Vanderbilt University, co-founding a concierge medical practice on Martha's Vineyard, international teaching and humanitarian work, and service in roles ranging from hospital administration to disaster relief—all grounded in a deep commitment to learning, mentorship, and collaboration.

In this episode of Revolutionary Women, I speak with Kyla Reynolds P'an, Head of Development for Pangea Trust, a UK–Portugal charity building Europe's first large-scale elephant sanctuary in Portugal's Alentejo region. Pangea Trust is creating a sanctuary for elephants currently living in captivity across Europe, offering a lifelong home designed for recovery, space, and social connection. We discuss what it takes to build an elephant sanctuary from the ground up, from fundraising and public awareness to infrastructure, international logistics, and preparing for the arrival of Kariba, the sanctuary's first elephant, expected in 2026. Beyond wildlife conservation, this conversation explores career evolution, living between cultures, and how seasons of work, including raising a family, shape the paths we take later. Kyla shares what it looks like to step into a new chapter with clarity and purpose. If you're interested in elephant conservation, nonprofit leadership, philanthropy in Europe, or stories of women creating change in their communities, this episode offers both depth and perspective. Kyla Reynolds P'an is Head of Development for Pangea Trust, a UK/Portugal based charity building Europe's largest and most comprehensive elephant sanctuary in the Alentejo region of Portugal. The sanctuary will serve as a compassionate solution for Europe's zoos and circuses seeking a life-long home for their elephants. Kyla holds a Master's in Journalism and is the mom of two teenagers. She has more than 20 years of front-line development experience under her belt, including the Smithsonian Institution, Boston University, Harvard Medical School and Mass Audubon. To Learn More about Kyla Reynolds P'an: LinkedIn: https://www.linkedin.com/in/kyla-p-an-59b1131/ To learn more about Pangea Trust: Home - Pangea Trust (2) Pangea Trust: Posts | LinkedIn (20+) Facebook (7) Instagram . . . . . Time to Shine by tubebackr & Popsicles https://soundcloud.com/tubebackr https://soundcloud.com/popsiclesmusic Creative Commons — Attribution-NoDerivs 3.0 Unported — CC BY-ND 3.0 Free Download / Stream: https://www.audiolibrary.com.co/tubebackr-and-popsicles/time-to-shine Music promoted by Audio Library https://youtu.be/Cvbjhx6X4ZY

The Blueprint: Dr. Cray Noah, MD Returns- 2.0 (UCLA/Harvard/Georgia Tech)---Innovation isn't accidental; it's designed. Welcome to The Blueprint, a show committed to inventing the future and closing the gap between aspiration and achievement. We deconstruct the mechanics of success in modern science to provide access to the insights that matter most.On this episode with Dr. Cray and Chadwin Hanna (MD-PhD Student at University of Florida), we sit down again in December 2025, five years after his initial guest appearance with Dr. Cray Noah, a General Surgery Resident at UCLA and an emerging leader at the intersection of engineering and medicine. A graduate of Harvard Medical School and a summa cum laude Biomedical Engineer from Georgia Tech, Cray has a track record of moving technical ideas from concept to clinical practice.We dive deep into his journey, and have real conversations on wellness, success and the journey of being a surgery resident.Also, this conversation includes:The Future of Transplants: His current feasibility study using hematopoietic stem cells to eliminate long-term immunosuppression in liver transplant recipients.From the GT environment to the operating room, this is a masterclass in navigating—and leading—the next era of discovery.Definitely an episode worth listening to. Please note: The views of this podcast represent those of my guest and I, and do not constitute medical advice, suggestions, or opinions. We disclaim any loss in any way.Music is open source.

Dr. Robert Waldinger, director of the Harvard Study of Adult Development, shares insights from the world's longest study on happiness, tracking over 2,500 people since 1938. The core finding: A good life comes from caring for your body and relationships, as warm connections predict health and longevity better than cholesterol levels at midlife. Privilege doesn't guarantee happiness, as inner-city participants matched Harvard men in well-being.Guest Introduction:Dr. Waldinger is a Harvard Medical School professor, psychiatrist, psychoanalyst, and Zen master who directs the 85+ year Harvard Study. His TED Talk has over 50 million views, and he co-authored The Good Life with Marc Schulz, distilling study lessons on connection. He teaches meditation globally and psychotherapy at Mass General Hospital.Connect With Guest:Website: robertwaldinger.com Book: The Good Life: Lessons from the World's Longest Scientific Study of Happiness.TED Talk: "What makes a good life? Lessons from the longest study on happiness".LinkedIn: Robert WaldingerWhat to do next: Click to grab our free guide, 10 Key Issues to Consider as You Explore Your Retirement Transition Please leave a review at Apple Podcasts. Join our Revolutionize Your Retirement group on Facebook.

Nessa live, eu conversei com o biomédico e pesquisador Dr. Andrew Koutnik (@andrewkoutnikphd)Dr. Andrew Koutnik é um cientista cuja carreira integra ciência de ponta, performance de elite e experiência pessoal vivendo com diabetes tipo 1 há mais de 17 anos. Doutor em Ciências Médicas (Farmacologia e Fisiologia Molecular) pela University of South Florida, ele desenvolveu pesquisas financiadas por instituições como NASA, Departamento de Defesa dos EUA e NIH, acumulando mais de 100 publicações e apresentações científicas internacionais. Seu trabalho investiga como nutrição, metabolismo e estilo de vida podem otimizar saúde, desempenho e resiliência — tanto em doenças crônicas quanto em contextos de alta exigência física.Atualmente professor no Institute for Sports Science and Medicine da Florida State University, Dr. Koutnik lidera estudos sobre fisiologia do exercício, saúde cardiometabólica e nutrição terapêutica, incluindo estratégias dietéticas para diabetes tipo 1 e 2, obesidade, sono e performance sob estresse metabólico. Colabora com instituições como Harvard Medical School e Boston Children's Hospital. Sua missão central é promover saúde metabólica baseada em evidência, ajudando indivíduos — inclusive atletas de elite — a alcançarem alto desempenho mesmo diante de desafios crônicos. Fora do laboratório, dedica-se à família e à prática de Brazilian Jiu Jitsu e treinamento físico.No Clube de Leitura, exploramos juntos obras que desafiam o senso comum — livros que unem ciência, filosofia e ancestralidade — sempre com uma visão crítica e prática para transformar o conhecimento em ação.

I want to start off by asking a question I continually interest myself with. Do we really want to be happy? If I survey the culture, it looks like we very much want happy moments. The little jolts of dopamine from entertainment, food, drugs and such. But do we really want deep and abiding happiness in our souls? Because if we do, then our primary interest would be in relationships. But not just any relationships. I'm revisiting a conversation I had with Robert Waldinger. Robert is a professor of psychiatry at Harvard Medical School and director of the Harvard Study of Adult Development at Massachusetts General Hospital which has been going on for 87 years. His devotion is on what most equates to human happiness, and the answer is, relationships. But let me point out that Robert himself is a Zen master and teaches meditation around the world. Which is a focus on what I feel is our first and most important relationship. The relationship with ourselves. I have continued to grow in appreciation, not just for the message, but for Robert himself. If you have my book, What Drives You, you'll see his endorsement. Roberts book, which is how I came to know of him, is, The Good Life: Lessons From the World's Longest Scientific Study on Happiness. And you type in, “Robert Waldinger TED” you will find his TED talk, titled, What Makes A Good Life, that between postings on both YouTube and TED has over 80 million views. Sign up for your $1/month trial period at shopify.com/kevin Go to shipstation.com and use code KEVIN to start your free trial. Learn more about your ad choices. Visit megaphone.fm/adchoices

Most of us have been trained to think of treating people as a technical problem. If something hurts, we look for the right drug. If something fails, we look for the right procedure. That picture is incomplete.We've built a system obsessed with fixing bodies, while quietly ignoring the inner worlds of the people living inside them. Their fears, their beliefs, their unanswered prayers, and the meaning they're trying to make of suffering.Illness doesn't just attack organs. It raises questions about God, identity, guilt, fear, and loss of control. And when those questions go unanswered, suffering multiplies, no matter how advanced the treatment plan is.Modern medicine has no real language for this kind of pain. It knows how to measure blood pressure, inflammation, and tumor size, but it doesn't know how to sit with grief, spiritual doubt, uncertainty, and loss.Yet when clinicians slow down enough to listen, something shifts. Patients begin to speak about meaning, about God, about unresolved relationships and fears they've never voiced before.And often, that is where real healing starts — the kind of whole-person healing that restores connection, dignity, and a sense of being spiritually held in the middle of suffering.What if some of the deepest healing doesn't come from doing more, but from being more present? How can clinicians learn to care for the soul as intentionally as they care for the body?In this episode, I speak with Dr. Marvin Delgado Guay, a palliative care specialist at MD Anderson Cancer Center. We talk about what it looks like when medicine includes spiritual care in its everyday practice. We explore why “total pain” includes the soul as much as the body, and how healthcare can become not just a place of treatment, but a space for healing, meaning, and connection with God.Things You'll Learn In This Episode Pain isn't always physicalMany symptoms labeled as “medical” are actually expressions of emotional or spiritual distress. What happens when we treat suffering instead of just symptoms?Fixing vs. healingMedicine is trained to solve problems, but some forms of suffering can't be solved, only witnessed. How does presence become a form of treatment?How spirituality shapes medical decisionsBeliefs about meaning, God, and purpose influence everything from treatment choices to end-of-life care, but are clinicians equipped to address this?The power of the “collective soul” in healthcareWhen doctors, nurses, chaplains, and therapists work as one, care becomes something deeper than specialization. What changes when healing becomes a shared human act?Guest BioDr. Marvin Delgado Guay is an internist and Assistant Professor in the Department of Palliative Care and Rehabilitation Medicine at MD Anderson Cancer Center, where he provides symptom control and supportive care for patients with advanced cancer and their caregivers. He completed his internal medicine training at Michael Reese Hospital in Chicago, followed by a fellowship in Geriatric Medicine at Harvard Medical School, and a clinical and research fellowship in Symptom Control and Palliative Care at MD Anderson. Earlier in his career, he coordinated palliative care services and worked within geriatrics at Lyndon B. Johnson General Hospital through the University of Texas Medical School. Dr. Delgado Guay's work focuses on what medicine often overlooks: the full experience of illness. His research explores physical, psychological, and spiritual distress in patients with serious disease, as well as aging-related issues such as frailty and cognition. He has authored and co-authored multiple peer-reviewed publications on symptom burden and spiritual care in advanced cancer, and is deeply committed to improving quality of...

Medicare for all. Not socialized medicine, just a single, government-run system that provides healthcare.  Is it possible? Or even viable? Our guest this week on the Creating a New Healthcare podcast believes so. In fact, he sees it as the only way to ultimately address the affordability problem with healthcare, particularly for high cost conditions like cancer. In today's episode, we talk with Dr. Troy Brennan about his book, The Transformation of American Health Insurance: On the Path to Medicare for All, and why a single payer, government system is needed, and how the changes the current administration has made to our public health systems is taking us backwards, not forward. Troyen Brennan is an Adjunct Professor at Harvard Chan School of Public Health.  He was formerly the Executive Vice President and Chief Medical Officer for CVS Health and Aetna. Before that, he was the President of the Brigham and Women's Physician Organization and Professor of Medicine at Harvard Medical School.  He was also Professor of Law and Public Health at the Harvard Chan School of Public Health.  Brennan was formerly the Chair of the American Board of Internal Medicine and is a member of the National Academy of Medicine. He has published six books and over 600 articles. 

In this episode, Dr. Andy Cutler talks with Dr. Tim Wilens about enduring myths surrounding ADHD diagnosis and treatment, beginning with why misconceptions about overdiagnosis and misuse continue to shape clinical hesitation. They explore common misunderstandings about ADHD medications—including stimulants versus non-stimulants, concerns about diversion, personality changes, and long-term safety—and contrast stigma-driven narratives with the clinical evidence. The conversation equips clinicians with practical, evidence-based strategies to address patient fears, counter misinformation, and make thoughtful, individualized treatment decisions.  Timothy Wilens, MD, is chief of the Division of Child and Adolescent Psychiatry and is co-director of the Center for Addiction Medicine at Massachusetts General Hospital. He is the MGH Trustees Chair in Addiction Medicine and a professor of psychiatry at Harvard Medical School. Dr. Wilens' research interests include the relationship among attention deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance use disorders, embedded health care models, and the pharmacotherapy of ADHD across the lifespan.   Andrew J. Cutler, MD, is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and EMA Wellness. He is a Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.  Save $100 on registration for 2026 NEI Spring Congress with code NEIPOD26  Register today at nei.global/spring  Never miss an episode!

Read "ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature" – co-authored by Dr. Anthony L. Komaroff & W. Ian Lipkin. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1187163/full    Fatigue is the body's hard-wired response to a viral infection. In today's episode, Haylie Pomroy shares insights with Dr. Anthony L. Komaroff to examine the history of ME/CFS research, the causes and triggers of ME/CFS and other post-infectious chronic illnesses, and the abnormalities observed in the brain and autonomic nervous system among patients with ME/CFS and long COVID. Dr. Komaroff also addresses how patients have often been dismissed within the healthcare system, explains the physical and psychological processes involved in these conditions, and discusses how he and other clinicians are now moving to the forefront of diagnosis and treatment.   Register for the Integrative Medicine Luncheon featuring Dr. Payam Hakimi on  February 14, 2026. https://nova.zoom.us/meeting/register/RQnykYIKRZO-yVykmDp-YQ#/registration   Dr. Anthony L. Komaroff is a distinguished Professor of Medicine at Harvard Medical School and a Senior Physician at Brigham and Women's Hospital. He has held significant leadership roles, including Director of the Division of General Medicine and Primary Care at Brigham and Women's Hospital. Dr. Komaroff is known for his research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and human herpesvirus infections. He has published over 270 research articles and book chapters and served on numerous advisory committees for major health organizations.   LinkedIn: https://www.linkedin.com/in/anthony-l-komaroff-64133346/  Facebook: https://web.facebook.com/anthonyl.komaroff    Solve ME: https://solvecfs.org  Open Medicine Foundation: https://www.omf.ngo  National Institutes of Health (NIH): https://www.nih.gov/mecfs/about-mecfs  Centers for Disease Control and Prevention (CDC): https://www.cdc.gov/me-cfs/about/index.html   Haylie Pomroy, Founder and CEO of The Haylie Pomroy Group, is a leading health strategist specializing in metabolism, weight loss, and integrative wellness. With over 25 years of experience, she has worked with top medical institutions and high-profile clients, developing targeted programs and supplements rooted in the "Food is Medicine" philosophy. Inspired by her own autoimmune journey, she combines expertise in nutrition, biochemistry, and patient advocacy to help others reclaim their health. She is a New York Times bestselling author of The Fast Metabolism Diet.   Learn more about Haylie Pomroy's approach to wellness through her website: https://hayliepomroy.com   Instagram: https://www.instagram.com/hayliepomroy  Facebook: https://www.facebook.com/hayliepomroy  YouTube: https://www.youtube.com/@hayliepomroy/videos  LinkedIn: https://www.linkedin.com/in/hayliepomroy/  X: https://x.com/hayliepomroy    Enjoy our show? Please leave us a 5-star review so we can bring hope and help to others. You can also watch the show on our YouTube.https://www.youtube.com/@NSU_INIM   Sign up today for our newsletter. https://nova.us4.list-manage.com/subscribe?u=419072c88a85f355f15ab1257&id=5e03a4de7d    This podcast is brought to you by the Institute for Neuro-Immune Medicine. Learn more about us here.   Website: https://www.nova.edu/nim/ Facebook: https://www.facebook.com/InstituteForNeuroImmuneMedicine Instagram: https://www.instagram.com/NSU_INIM/ Twitter: https://www.twitter.com/NSU_INIM

Synopsis: At JPM 2026 in San Francisco, Alok Tayi welcomes Michelle Werner, CEO of Alltrna, to Biotech 2050 for a powerful conversation at the intersection of personal mission, platform biology, and rare-disease drug development. Michelle traces her two-decade career across Bristol Myers Squibb, AstraZeneca, and Novartis—and the moment everything changed when her child was diagnosed with a rare disease. That experience led her to Alltrna and its pioneering engineered tRNA platform, designed to correct nonsense mutations across hundreds—potentially thousands—of genetic disorders with a single therapeutic approach. Together, Alok and Michelle explore how tRNAs work, why “stop-codon disease” could redefine rare-disease classification, and how basket trials borrowed from oncology may accelerate development. They dive into delivery strategy, portfolio expansion into CNS and muscle disorders, regulatory innovation, and how AI is reshaping molecular design—offering a rare look at what it takes to build a first-in-class modality from the ground up. Biography: Michelle is a seasoned pharmaceutical executive with more than 20 years in the industry spanning commercial and research & development (R&D) responsibilities. Prior to Alltrna, Michelle served as Worldwide Franchise Head, Solid Tumors at Novartis Oncology, where she was responsible for delivering the disease area strategies across multiple tumors and led business development efforts resulting in a doubling of long-term portfolio value for the franchise. Previous to Novartis, Michelle was a senior leader at AstraZeneca and as Global Franchise Head in Hematology, she was critical in launching multiple indications worldwide for CALQUENCE®. Prior to this, Michelle was Head of US Oncology, where she led the business through dramatic growth in both team and revenue through eight-plus product launches. Previous to AstraZeneca, Michelle was with Bristol-Myers Squibb for 10 years in various positions of increasing responsibility including roles in sales, marketing, and market access in the US and UK, and above market in Europe (based in France) and global almost exclusively in oncology. Michelle started her professional career in R&D, working hands-on with patients at the Oncology Clinical Trials Unit at Harvard Medical School before moving into industry in clinical operations. Outside of her corporate responsibilities, Michelle is a wife and mother to three children and is a member of the rare disease community. She is currently serving a Board appointment for the non-profit organization Rare Disease Renegades, a purpose that fuels her passions both personally and professionally.

In episode 67 of Going anti-Viral, Dr Martin Hirsch joins host Dr Michael Saag to discuss his career in HIV medicine, mentorship, and his scientific legacy. Dr Hirsch is a Professor Emeritus at Harvard Medical School and was Director of the Harvard Collaborative AIDS Treatment Evaluation Unit from 1986 to 2003 and Director of the Harvard Multidisciplinary AIDS Research Training Grant. Dr Hirsch's research focused on finding drug combinations that delay the development of multidrug resistance and reduce viral replication in HIV-1 infection. Dr Hirsch served as an Editorial Board member for numerous prestigious medical journals over the past 3 decades, including AIDS, the New England Journal of Medicine, Clinical Infectious Diseases, and the Journal of Infectious Diseases, where he was Editor-in-Chief. Dr Hirsch discusses his extensive career, the evolution of antiviral therapies, and the importance of mentorship in science. He reflects on his early experiences, the emergence of HIV, and the collaborative efforts that led to advancements in treatment. Dr Hirsch emphasizes the need for individualized mentorship and shares insights on the future of HIV research and his optimism for the potential of HIV prophylactic treatments.0:00 – Introduction1:50 – Early career and mentorship5:07 – Transitioning to HIV research7:55 – The emergence of antiretroviral therapies11:06 – The AIDS epidemic and initial cases14:30 – Collaboration in HIV research17:42 – The AZT trial and its impact20:16 – Navigating the shift from CMV to HIV22:39 – Antiretroviral resistance and combination therapy26:39 – The role of mentorship in science30:56 – Future directions in HIV researchResources:Going-anti-Viral: Episode 6 - A Conversation With Dr Anthony Fauci __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

In this episode, Dr. Greg Jones sits down with Dr. Sharon Hausman-Cohen, Chief Medical Officer of IntelliXX DNA, to explore how medical genomics is transforming the way we understand heart disease, brain health, inflammation, and metabolism. Most people think genetics stops at traits like eye color or ancestry. Genomics goes much deeper—analyzing how thousands of genes interact to influence cardiovascular risk, cognitive function, clotting tendencies, nutrient metabolism, and chronic inflammation.Dr. Hausman-Cohen explains why many direct-to-consumer DNA tests fall short, how incomplete interpretation can mislead patients, and why clinician-guided genomic analysis allows for truly personalized care. The conversation also dives into inflammation, methylation, homocysteine, cholesterol myths, caffeine metabolism, mitochondrial health, and women's unique clotting risks.Whether you're trying to reduce your risk of heart disease, improve mental clarity, or understand how your biology responds to diet, supplements, and medications—this episode offers a science-based roadmap for precision health.

Send us a textNavigating Childhood Tics and Tourette Syndrome: Expert Insights with Dr. GreenbergIn this  episode, we sit down with Dr. Greenberg, director of the pediatric psychiatry OCD and Tic disorders program in Boston, to discuss the complexities of childhood tics and Tourette Syndrome. Dr. Greenberg shares his extensive expertise and personal experiences to help parents understand what tics are, how they manifest, and their natural progression. He provides insights on effective treatments such as CBIT therapy and when medication might be necessary. Additionally, Dr. Greenberg emphasizes the importance of differentiating between normal tics and those that may indicate other co-occurring conditions like ADHD and OCD. This episode is a must-watch for parents seeking reassurance and practical advice on managing their child's tics.Erica Greenberg, M.D. is an assistant Professor in Psychiatry at Harvard Medical School and a child/adolescent psychiatrist at Massachusetts General Hospital (MGH) where she is the Director of the Pediatric Psychiatry OCD and Tic Disorders Program. Dr. Greenberg is also a co-Director of the MGH Tourette Association of America (TAA) Center of Excellence and the co-president of the Medical Advisory Board of the TAA. Her interests include Tourette syndrome (TS), OCD, “Tourettic OCD,” ADHD, body-focused repetitive behavior disorders, and other Tourette syndrome spectrum conditions. She has authored several peer-reviewed manuscripts on TS, OCD, and related disorders, and has presented on these conditions nationally and internationally. Dr. Greenberg graduated from Weill Cornell Medical College with Alpha Omega Alpha honors, and completed her general psychiatry residency at Harvard Longwood and her child/adolescent fellowship training at MGH.Contact Dr Greenberg: MassGeneral Brigham; Massachusetts General Hospital for ChildrenPediatric Psychiatry OCD and Tic Disorders ProgramEmail: MGHPediOCDTics@partners.org617-643-2780Your Child is Normal is the trusted podcast for parents, pediatricians, and child health experts who want smart, nuanced conversations about raising healthy, resilient kids. Hosted by Dr. Jessica Hochman — a board-certified practicing pediatrician — the show combines evidence-based medicine, expert interviews, and real-world parenting advice to help listeners navigate everything from sleep struggles to mental health, nutrition, screen time, and more. Follow Dr Jessica Hochman:Instagram: @AskDrJessica and Tiktok @askdrjessicaYouTube channel: Ask Dr Jessica If you are interested in placing an ad on Your Child Is Normal click here or fill out our interest form.-For a plant-based, USDA Organic certified vitamin supplement, check out : Llama Naturals Vitamin and use discount code: DRJESSICA20-To test your child's microbiome and get recommendations, check out: Tiny Health using code: DRJESSICA The information presented in Ask Dr Jessica is for general educational purposes only. She does not diagnose medical conditi...

Sergio Alfaro, Army Medic and GWOT veteran, in Episode 234 of the Transition Drill Podcast, his experience highlights the importance of preparing for the mental and emotional side of transition, not just the next job or degree, and building support systems early instead of relying on a single post-service plan. Ultimately, his path reinforces that successful transition preparation requires adaptability, self-awareness, and permission to redefine success when the original mission no longer fits.Sergio talks about Iraq, PTSD, and the long road from wanting to become a doctor to rebuilding a life that actually works. If you're a veteran or first responder trying to figure out who you are after the job, this one's for you.Sergio was born in Los Angeles and grew up in Maywood and Burbank, seeing two very different worlds early on. He joined the Army with a long-term plans of becoming a doctor. In the Army, he became a medic, trained and deployed to Iraq in 2003–2004, based in Hamadi, west of Fallujah. He describes the reality of frequent mortar attacks, watching for IED threats, and the kind of moments that never really leave you. He also shares the loss of his commanding officer overseas, and how survivor's guilt and “why him, not me” thinking followed him home.After one enlistment, that turned into four and a half years because of stop-loss, Sergio struggled with trauma, but was hopeful of getting the option for the Army to send him to college to be a doctor. He wanted to keep serving and also go to school, but he ran into the “ask command” reality of the system, and it changed his outlook on staying in. He got out, determined to chase the goal on his own terms.That drive carries him all the way to acceptance at Harvard Medical School, with the GI Bill and Yellow Ribbon support helping make it possible. But also dealing with PTSD, a medical culture not built for that, and a training path that puts him in a VA inpatient psych ward rotation at the worst possible time. Things spiral, and he shares what it's like when your identity is tied to one mission and you feel it slipping away.The second half of this conversation is about what actually helped: support systems, weekly check-ins, and eventually getting connected with Wounded Warrior Project's Warriors to Work, job fairs, resume feedback, and a shift toward a new career path built around what he always loved most, training and teaching others.CONNECT WITH THE PODCAST:Instagram: https://www.instagram.com/paulpantani/WEBSITE: https://www.transitiondrillpodcast.comLinkedIn: https://www.linkedin.com/in/paulpantani/SIGN-UP FOR THE NEWSLETTER:https://transitiondrillpodcast.com/home#aboutQUESTIONS OR COMMENTS:paul@transitiondrillpodcast.comSPONSORS:GRND CollectiveGet 15% off your purchaseLink: https://thegrndcollective.com/Promo Code: TRANSITION15Blue Line RoastingGet 10% off your purchaseLink: https://bluelineroasting.comPromocode: Transition10Frontline OpticsGet 10% off your purchaseLink: https://frontlineoptics.comPromocode: Transition10

Love the episode? Send us a text!What happens when a breast surgeon becomes a breast cancer patient—and then faces a second diagnosis years later?In this deeply personal and illuminating episode of Breast Cancer Conversations, host Laura Carfang is joined by Dr. Anne Peled, a board-certified breast, reconstructive, and plastic surgeon who has treated thousands of patients—and also navigated her own early-stage breast cancer diagnosis, followed years later by a new primary DCIS diagnosis.Together, Laura and Dr. Peled unpack what patients are rarely told about DCIS (stage zero breast cancer), the difference between recurrence and a second primary cancer, and how advances in surgery are transforming survivorship—including sensation-preserving mastectomy.This conversation bridges clinical expertise and lived experience, offering clarity, compassion, and permission to choose the path that aligns with your body and values.In this episode: What DCIS really is—and why “stage zero” can be misleadingRecurrence vs. second primary breast cancer: why biology mattersLumpectomy vs. mastectomy and why survival outcomes are often the sameHow guilt and self-blame show up after a second diagnosisBeing diagnosed with breast cancer as a physicianNavigating treatment when your colleagues are your caregiversThe evolution of oncoplastic surgery and patient-centered careWhy loss of breast sensation is under-discussed—but life-changingHow sensation-preserving mastectomy worksWhat questions to ask your surgeon about sensation, nerves, and recoveryMaking decisions based on your priorities—not fear or pressureAbout today's guestDr. Anne Peled is a board-certified plastic, reconstructive, and breast surgeon in private practice in San Francisco and Co-Director of the Sutter Health California Pacific Medical Center Breast Cancer Center of Excellence. Trained at Amherst College, Harvard Medical School, and UCSF, Dr. Peled completed a unique fellowship combining breast oncologic surgery and reconstruction.Her clinical and research work focuses on oncoplastic surgery, preserving and restoring sensation after mastectomy, improving patient outcomes, and breast cancer risk reduction. She is also a breast cancer survivor herself, bringing rare dual insight to patient care. Support the showLatest News: Become a Breast Cancer Conversations+ Member! Sign Up Now. Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources! Enjoying our content? Please consider supporting our work.

In this episode of The Talking Gut Podcast, Dr Jim Kantidakis sits down with Professor Ted J. Kaptchuk, Professor of Medicine at Harvard Medical School and Director of the Program in Placebo Studies and the Therapeutic Encounter at Beth Israel Deaconess Medical Center. Professor Kaptchuk is one of the world's leading researchers in placebo science. His groundbreaking 2010 study, Placebos Without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome, demonstrated that patients with IBS improved even when they knowingly took a placebo — challenging long-held assumptions about mind–body interactions and symptom perception. In this conversation, we explore: What the placebo effect really is — and what it isn't Why IBS and other gut–brain disorders show high placebo response rates How open-label placebo works without deception The neurobiology of expectation, ritual, and healing What the "therapeutic encounter" means for modern clinical practice This episode invites clinicians and patients alike to rethink symptoms, perception, and the powerful role of context in healing.

Imagine being afraid of a pickle. Or a banana. Or a nub of bread. That’s daily life for people with ARFID (Avoidant/Restrictive Food Intake Disorder). It's an eating disorder not driven by weight or body image, but by fear, sensory overwhelm, or low appetite. People with this condition experience real terror and powerful aversions to certain foods - far beyond picky eating. Clinical psychologist Dr. Evelyna Kambanis explains ARFID, who it affects, and how treatment helps people reclaim their lives. Andrew Luber (aka “ARFID Andrew”) shares his funny, blunt, and vulnerable attempts at food exposures online. And Danielle Meinert tells the story of carrying ARFID since toddlerhood, and the startling change she says came after a high-dose psilocybin experience. Resources: National Eating Disorders Association - ARFIDAssociation of Anorexia Nervosa and Associated DisordersFamilies Empowered and Supporting Treatment of Eating Disorders Suggested episodes: The hidden hunger of Pica: Stories from people who eat objects Anorexia is complex. Two people talk frankly about their decades-long journeys GUESTS: Dr. Evelyna Kambanis: Licensed clinical psychologist in the Eating Disorders Clinical & Research Program at Massachusetts General Hospital and a faculty member at Harvard Medical School. She is involved in clinical care and research on ARFID Andrew Luber, aka ARFID Andrew: Los Angeles filmmaker and social media creator who documents food exposures with humor under the tagline, “Conquering my fear of food one laugh at a time” Danielle Meinert: Lived with ARFID for 27 years after a major shift in her relationship with food following ear surgery as a toddler. After years of trying traditional approaches, she described experiencing a dramatic change after a session using psilocybin Support the show: https://www.wnpr.org/donateSee omnystudio.com/listener for privacy information.

“Time of Useful Consciousness “ (The aviation term for the time between when the oxygen cuts out, and the pilot is still conscious…) Caroline welcomes astro mytho colleague Judith Tsafrir, as we weave powerful testimony from Aliya Rahman, and Renee Good's brothers, Luke & Brent Ganger, rousing music – with the increasing rapidly arising dangers – with the descriptive & guiding astrological narrative of effective strategy. The Good Medicine of Bad Bunny Super Bowl, the Monks and Aloka. In Trickster We Trust …   Judy Tsafrir, MD is a physician, shamanic practitioner, and guide in the work of healing and human development. Trained in adult and child psychiatry and psychoanalysis, and a longtime Harvard Medical School faculty member, she brings an integrative approach that bridges depth psychology, holistic medicine, and spiritual wisdom. Judy draws on shamanism, astrology, the Tarot, Reiki, and intuitive practices, alongside her medical and psychoanalytic training, to support healing at emotional, physical, and spiritual levels. She is the author of Sacred Psychiatry: Bridging the Personal and Transpersonal to Transform Health and Consciousness., and her work is grounded in the belief that healing arises through the integration of heart, mind, body, and spirit—and that personal healing is inseparable from the healing of our communities and planet. https://www.JudyTsafrirMD.com The post Time of Useful Consciousness appeared first on KPFA.

In this episode, I sit down with one of my former mentors and professors, Dr. Alan Penzias, Medical Director at Boston IVF and Associate Professor at Harvard Medical School, to discuss his recent editorial in the Annals of Internal Medicine titled "The Weighty Issue of Obesity and Reproductive Success."  Read the full show notes on Dr. Aimee's website.  We dive deep into how age and weight factor into the fertility equation and why these conversations are so critical for anyone trying to conceive. Dr. Penzias shares his decades of experience helping patients navigate the complex intersection of body mass index, maternal age, and reproductive success, offering practical guidance on when to seek treatment and how to optimize your health before trying to get pregnant. In this episode, we cover: How age remains the strongest predictor of fertility success and why both partners should consider timing The U-shaped curve of BMI and fertility: why both low and high body mass index can impact conception Practical strategies for doctors for discussing weight and fertility with patients in a shame-free, empowering way When to prioritize immediate fertility treatment versus taking time for weight optimization based on age The role of GLP-1 medications (like Tirzepatide) in fertility treatment and safe protocols for use Why unexplained infertility may have hidden explanations related to weight and metabolic health The "do the as if" philosophy: building sustainable health habits one step at a time Resources: Dr. Alan Penzias and Boston IVF: BostonIVF.com Dr. Penzias's editorial: "The Weighty Issue of Obesity and Reproductive Success" - Annals of Internal Medicine https://www.acpjournals.org/doi/10.7326/ANNALS-25-02742  Dr. Penzias's YouTube video: "Evidence-Based Approach to Unexplained Infertility" https://youtu.be/9j4lNvmaXts?si=zmMFZFOno0sWnhcn  American Society for Reproductive Medicine (ASRM) Practice Committee resources on overweight and fertility https://www.asrm.org/ Dr. Stephanie Fein  - Fertility Weight Loss Specialist: https://www.stephaniefeinmd.com/  Hillary Wright, Nutritionist at Boston IVF: https://www.bostonivf.com/physicians/hillary-wright Do you have questions about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, February 9, 2026 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org. Other ways to connect with Dr. Aimee and The Egg Whisperer Show: Subscribe to my YouTube channel for more fertility tips!Subscribe to the newsletter to get updates  

In this episode of The MSing Link Podcast, I'm thrilled to welcome Dr. Kelly Rich, neuroscientist at Harvard Medical School, for a deep dive into how multiple sclerosis (MS) might accelerate brain aging—and what the latest research reveals. We explore the connection between MS, cellular aging, and innovative new therapies like cellular reprogramming that could help protect and rejuvenate your nervous system. Dr. Rich shares practical insights on supporting brain health, resilience, and ways to slow neurological decline. Whether you're looking to reduce MS fatigue, improve mobility, or boost your cognition, this episode is packed with expert advice, empowering exercises, and actionable tools for living better with MS. Tune in for an inspiring discussion on MS treatments, neuroscience, anti-inflammatory strategies, and hope for future breakthroughs in MS care! About Dr. Kelly Rich:  Dr. Kelly Rich, a neuroscientist and clinical genetic counselor at Harvard Medical School, who works in Dr. David Sinclair's lab studying how aging affects our nervous system at the cellular level. Connect with Dr. Kelly Rich:Instagram: https://www.instagram.com/kellyrichphd Connect with the Sinclair Lab:Instagram: https://www.instagram.com/sinclair_labWebsite: https://sinclair.hms.harvard.edu/?utm_source=ig&utm_medium=social&utm_content=link_in_bio&fbclid=PAZXh0bgNhZW0CMTEAc3J0YwZhcHBfaWQMMjU2MjgxMDQwNTU4AAGnPtOlP1oSYiX1wyDKp-8TxE5-kbY81__aH1AWVU_qn2JJGn-dihYq4uHn6Wg_aem_7n-6t_jlL2A68qgb0q7bVALifespan with Dr. David Sinclair Podcast: https://podcasts.apple.com/us/podcast/lifespan-with-dr-david-sinclair/id1601709306 Additional Resources: https://www.doctorgretchenhawley.com/insider Reach out to Me: hello@doctorgretchenhawley.com Website: www.MSingLink.com Social: ★ Facebook: https://www.facebook.com/groups/mswellness ★ Instagram: https://www.instagram.com/doctor.gretchen ★ YouTube: https://www.youtube.com/c/doctorgretchenhawley?sub_confirmation=1 → Game Changers Course: https://www.doctorgretchenhawley.com/GameChangersCourse → Total Core Program: https://www.doctorgretchenhawley.com/TotalCoreProgram → The MSing Link: https://www.doctorgretchenhawley.com/TheMSingLink

“My times were dropping and it was so exciting. Every week, they were dropping, dropping, dropping. It was pretty early in the season, too. At that point, I hadn't even made NCAAs. At the time when I ran 2:00, I had the number one time in the country. There was a lot that happened super fast… I think that was my favorite race of my life. I never even thought in my mind that I could run 2:00 even earlier on in the season. It broadened the horizons of what I think I'm capable of in the future and to never limit myself.”My guest for today's episode is Victoria Bossong. This week on the podcast, CITIUS MAG is bringing you interviews with some of Team New Balance's latest signees as we celebrate five years of partnering with them on all things from the high school to the professional front. Yesterday, we brought you an interview with Roisin Willis and now we've got another strong rising 800m runner.Victoria was a star high school sprinter in Maine who almost on a whim tried the 800m late into her prep career and found success. Fast forward a few years and she's fully committed to the event. In 2025 while at Harvard, she was the NCAA Indoor Championships runner-up and ran an outdoor personal best of 1:59.48. She just opened up her indoor season as a pro with an indoor 1000m PB of 2:36. Off the track, she's just as impressive. She has her degree in neuroscience and has worked in a Harvard Medical School lab. In our chat, she discusses how she managed to balance all of that as a student-athlete, how she comes at the 800m from more of a sprinter background, and her goals for her first professional season.____________Host: Chris Chavez | ⁠⁠@chris_j_chavez on Instagram⁠Guest: Victoria Bossong | @victoriabossong on InstagramProduced by: Jasmine Fehr | ⁠⁠⁠@jasminefehr on Instagram⁠⁠⁠____________SUPPORT OUR SPONSORSUSATF: The USATF Indoor Track and Field Championships presented by Prevagen are back in New York City from February 28th to March 1st at the Ocean Breeze Athletic Complex in Staten Island. This is where legends don't just race; they punch their ticket to the world stage. The pressure is real, the margins are razor thin, and every athlete is fighting for one thing: a spot on Team USATF at the World Indoor Championships. Grab your tickets now at USATF.org/tickets and experience track and field at its absolute loudest.OLIPOP: A blast from the past, Olipop's Shirley Temple combines smooth vanilla flavor with bright lemon and lime, finished with cherry juice for that nostalgic grenadine-like flavor. One sip of this timeless soda proves some flavors never grow old. Try Shirley Temple and more of Olipop's flavors at DrinkOlipop.com and use code CITIUS25 at checkout to get 25% off your orders.

Ewa Grassin jest naukowczynią na Harvard Medical School. W swojej pracy tworzy modele ludzkiego mózgu z komórek macierzystych, by lepiej zrozumieć choroby neurologiczne. W odcinku nauka jest jednak tylko punktem wyjścia. To rozmowa o tym, jak naprawdę wygląda kariera naukowa w Stanach Zjednoczonych: o drodze do pracy w jednym z najbardziej konkurencyjnych środowisk na świecie, presji grantów, zawodowej niepewności, statusie imigracyjnym i codzienności, która ma niewiele wspólnego z filmowym wyobrażeniem Harvardu.

I had the absolute pleasure of sitting down with Dr. Amy Comander on The Breast Cancer Podcast 

Most medical encounters are structured as transactions. The patient comes in with a specific complaint, the medical expert identifies a discrete problem, and a specific intervention is prescribed.But at the heart of a medical encounter is a story. When a patient comes in with a medical problem, the problem cannot be disentangled from their life's narrative — doing so risks hollowing out the essence of what it means to care for another person. Our guest on this episode is award-winning author, and primary care physician Suzanne Koven, MD. Following the completion of her residency at Johns Hopkins Hospital, Dr. Koven joined the faculty at Harvard Medical School and practiced primary care medicine at Massachusetts General for 32 years. In 2019, she became the inaugural Writer in Residence at Mass General. Her writings have been published broadly—including in The Boston Globe, The New England Journal of Medicine, The Lancet, and The New Yorker. As a teacher and public speaker, she highlights the relationship between literature and medicine, and is a powerful advocate for female medical trainees. In this episode, Dr. Koven shares her journey to medicine at a time when few women were represented in the field and why she finds her undergraduate English classes to be more relevant to her clinical work than her science classes. We discuss narrative medicine, its value to patients and physicians alike, and how the modern healthcare system struggles to value the patient story. Finally, Dr. Koven leaves us with her advice for up-and-coming trainees: find a place in medicine where you can be yourself – for your own good and for your patients'.In this episode, you'll hear about: 3:00 - Dr. Koven's motivations for going into primary care medicine 15:49 - The impact that Dr. Koven's English degree has had on her approach to medicine 19:36 - What narrative medicine is 24:34 - What is lost when human connection and human story are deprioritized within the practice of medicine 31:15 - The benefits doctors experience when cultivating an appreciation for the arts37:21 - How gender representation in medicine has shaped Dr. Koven's experience as a physician42:54 - The need for the culture of medicine to adapt to changing demographics in the medical workforceIf you enjoyed this episode, please subscribe, rate, and review our show, available for free on Spotify, Apple Podcasts, or wherever you get your podcasts. If you know of a doctor, patient, or anyone working in health care who would love to explore meaning in medicine with us on the show, feel free to leave a suggestion in the comments or send an email to info@thedoctorsart.com.Copyright The Doctor's Art Podcast 2026